Evidence map›Paper›PMID 25978422›Full record

ArticlePLoS neglected tropical diseases2015

Bacterial Factors Associated with Lethal Outcome of Enteropathogenic Escherichia coli Infection: Genomic Case-Control Studies.

Michael S Donnenberg, Tracy H Hazen, Tamer H Farag, Sandra Panchalingam, Martin Antonio, Anowar Hossain, Inacio Mandomando, John Benjamin Ochieng, Thandavarayan Ramamurthy, Boubou Tamboura and 5 more

Abstract readMulticenter Study
In one paragraph

Article in PLoS neglected tropical diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Enteropathogenic Escherichia coli Infection in Cancer and Immunosuppressed Patients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  6. Article
  7. Factors associated with typical enteropathogenicEpidemiology and infection · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Michael S DonnenbergDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Tracy H HazenInstitute for Genome Sciences, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Tamer H FaragDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Sandra PanchalingamCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Martin AntonioMedical Research Council, Fajara, The Gambia.
Anowar HossainInternational Center for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Inacio MandomandoCentro de Investigacao em Saude de Manhica, Maputo, Mozambique.
John Benjamin OchiengKenya Medical Research Institute/Center for Disease Control, Kisumu, Kenya.
Thandavarayan RamamurthyNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Boubou TambouraCenter for Vaccine Development-Mali, Bamako, Mali.
Anita ZaidiThe Aga Khan University, Karachi, Pakistan.
Myron M LevineCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Karen KotloffCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
David A RaskoInstitute for Genome Sciences, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
James P NataroDepartment of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia, United States of America.

Funding

Severe Enteric Disease: Pathogenesis and ResponseU19AI090873 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BOWER, DONNA ADAMS · 2010 to 2014
$7.2M
Medical Research Council MC_U190074190Medical Research Council MC_U190081991NIAID NIH HHS U19 AI090873NIAID NIH HHS U19AI090873
6 · The paper itself

Abstract

backgroundTypical enteropathogenic Escherichia coli (tEPEC) strains were associated with mortality in the Global Enteric Multicenter Study (GEMS). Genetic differences in tEPEC strains could underlie some of the variability in clinical outcome.

methodsWe produced draft genome sequences of all available tEPEC strains from GEMS lethal infections (LIs) and of closely matched EPEC strains from GEMS subjects with non-lethal symptomatic infections (NSIs) and asymptomatic infections (AIs) to identify gene clusters (potential protein encoding sequences sharing ≥90% nucleotide sequence identity) associated with lethality.

resultsAmong 14,412 gene clusters identified, the presence or absence of 392 was associated with clinical outcome. As expected, more gene clusters were associated with LI versus AI than LI versus NSI. The gene clusters more prevalent in strains from LI than those from NSI and AI included those encoding proteins involved in O-antigen biogenesis, while clusters encoding type 3 secretion effectors EspJ and OspB were among those more prevalent in strains from non-lethal infections. One gene cluster encoding a variant of an NleG ubiquitin ligase was associated with LI versus AI, while two other nleG clusters had the opposite association. Similar associations were found for two nleG gene clusters in an additional, larger sample of NSI and AI GEMS strains.

conclusionsParticular genes are associated with lethal tEPEC infections. Further study of these factors holds potential to unravel the mechanisms underlying severe disease and to prevent adverse outcomes.

Indexed as

Case-Control StudiesChildChild, PreschoolEnteropathogenic Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsGenes, BacterialGenomicsHumansInfantMultigene FamilyO AntigensEscherichia coli ProteinsO Antigens

Identifiers

PMID25978422
PMCPMC4433268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.